Nitric oxide modulates the catalytic activity of myeloperoxidase - PubMed (original) (raw)
. 2000 Feb 25;275(8):5425-30.
doi: 10.1074/jbc.275.8.5425.
Affiliations
- PMID: 10681518
- DOI: 10.1074/jbc.275.8.5425
Free article
Nitric oxide modulates the catalytic activity of myeloperoxidase
H M Abu-Soud et al. J Biol Chem. 2000.
Free article
Abstract
Myeloperoxidase (MPO), an abundant protein in neutrophils, monocytes, and subpopulations of tissue macrophages, is believed to play a critical role in host defenses and inflammatory tissue injury. To perform these functions, an array of diffusible radicals and reactive oxidant species may be formed through oxidation reactions catalyzed at the heme center of the enzyme. Myeloperoxidase and inducible nitric-oxide synthase are both stored in and secreted from the primary granules of activated leukocytes, and nitric oxide (nitrogen monoxide; NO) reacts with the iron center of hemeproteins at near diffusion-controlled rates. We now demonstrate that NO modulates the catalytic activity of MPO through distinct mechanisms. NO binds to both ferric (Fe(III), the catalytically active species) and ferrous (Fe(II)) forms of MPO, generating stable low-spin six-coordinate complexes, MPO-Fe(III).NO and MPO-Fe(II).NO, respectively. These nitrosyl complexes were spectrally distinguishable by their Soret absorbance peak and visible spectra. Stopped-flow kinetic analyses indicated that NO binds reversibly to both Fe(III) and Fe(II) forms of MPO through simple one-step mechanisms. The association rate constant for NO binding to MPO-Fe(III) was comparable to that observed with other hemoproteins whose activities are thought to be modulated by NO in vivo. In stark contrast, the association rate constant for NO binding to the reduced form of MPO, MPO-Fe(II), was over an order of magnitude slower. Similarly, a 2-fold decrease was observed in the NO dissociation rate constant of the reduced versus native form of MPO. The lower NO association and dissociation rates observed suggest a remarkable conformational change that alters the affinity and accessibility of NO to the distal heme pocket of the enzyme following heme reduction. Incubation of NO with the active species of MPO (Fe(III) form) influenced peroxidase catalytic activity by dual mechanisms. Low levels of NO enhanced peroxidase activity through an effect on the rate-limiting step in catalysis, reduction of Compound II to the ground-state Fe(III) form. In contrast, higher levels of NO inhibited MPO catalysis through formation of the nitrosyl complex MPO-Fe(III)-NO. NO interaction with MPO may thus serve as a novel mechanism for modulating peroxidase catalytic activity, influencing the regulation of local inflammatory and infectious events in vivo.
Similar articles
- Interrogation of heme pocket environment of mammalian peroxidases with diatomic ligands.
Abu-Soud HM, Hazen SL. Abu-Soud HM, et al. Biochemistry. 2001 Sep 11;40(36):10747-55. doi: 10.1021/bi010478v. Biochemistry. 2001. PMID: 11535049 - A novel multistep mechanism for oxygen binding to ferrous hemoproteins: rapid kinetic analysis of ferrous-dioxy myeloperoxidase (compound III) formation.
Abu-Soud HM, Raushel FM, Hazen SL. Abu-Soud HM, et al. Biochemistry. 2004 Sep 14;43(36):11589-95. doi: 10.1021/bi049541h. Biochemistry. 2004. PMID: 15350145 - Thiocyanate modulates the catalytic activity of mammalian peroxidases.
Tahboub YR, Galijasevic S, Diamond MP, Abu-Soud HM. Tahboub YR, et al. J Biol Chem. 2005 Jul 15;280(28):26129-36. doi: 10.1074/jbc.M503027200. Epub 2005 May 13. J Biol Chem. 2005. PMID: 15894800 - [Oxides of nitrogen (NO* and NO2-) as cofactors of the myeloperoxidase system].
But PG, Murav'ev RA, Fomina VA, Rogovin VV. But PG, et al. Izv Akad Nauk Ser Biol. 2004 May-Jun;(3):269-73. Izv Akad Nauk Ser Biol. 2004. PMID: 15354951 Review. Russian. - Myeloperoxidase-generated oxidants and atherosclerosis.
Podrez EA, Abu-Soud HM, Hazen SL. Podrez EA, et al. Free Radic Biol Med. 2000 Jun 15;28(12):1717-25. doi: 10.1016/s0891-5849(00)00229-x. Free Radic Biol Med. 2000. PMID: 10946213 Review.
Cited by
- Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus.
Bouali H, Nietert P, Nowling TM, Pandey J, Dooley MA, Cooper G, Harley J, Kamen DL, Oates J, Gilkeson G. Bouali H, et al. J Rheumatol. 2007 Oct;34(10):2028-34. Epub 2007 Sep 15. J Rheumatol. 2007. PMID: 17896805 Free PMC article. - Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition.
Galijasevic S, Saed GM, Diamond MP, Abu-Soud HM. Galijasevic S, et al. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14766-71. doi: 10.1073/pnas.2435008100. Epub 2003 Dec 1. Proc Natl Acad Sci U S A. 2003. PMID: 14657339 Free PMC article. - Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.
Shishehbor MH, Hazen SL. Shishehbor MH, et al. Curr Atheroscler Rep. 2004 May;6(3):243-50. doi: 10.1007/s11883-004-0038-1. Curr Atheroscler Rep. 2004. PMID: 15068750 Review. - Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.
Shaeib F, Khan SN, Ali I, Najafi T, Maitra D, Abdulhamid I, Saed GM, Pennathur S, Abu-Soud HM. Shaeib F, et al. PLoS One. 2015 Apr 2;10(3):e0120737. doi: 10.1371/journal.pone.0120737. eCollection 2015. PLoS One. 2015. PMID: 25835505 Free PMC article. - Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction.
Quinn M, Zhang RYK, Bello I, Rye KA, Thomas SR. Quinn M, et al. Antioxidants (Basel). 2024 Jun 28;13(7):788. doi: 10.3390/antiox13070788. Antioxidants (Basel). 2024. PMID: 39061857 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous